Fonte: European Journal of Pharmacology. Unidade: FMRP
Assunto: FARMACOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
POMPERMAYER, Kenia et al. Effects of the treatment with glibenclamide, an ATP-sensitive potassium channel blocker, on intestinal ischemia and reperfusion injury. European Journal of Pharmacology, v. 556, n. 1-3, p. 215-222, 2007Tradução . . Disponível em: https://doi.org/10.1016/j.ejphar.2006.10.065. Acesso em: 15 out. 2024.APA
Pompermayer, K., Amaral, F. A., Fagundes, C. T., Vieira, A. T., Cunha, F. de Q., Teixeira, M. M., & Souza, D. G. (2007). Effects of the treatment with glibenclamide, an ATP-sensitive potassium channel blocker, on intestinal ischemia and reperfusion injury. European Journal of Pharmacology, 556( 1-3), 215-222. doi:10.1016/j.ejphar.2006.10.065NLM
Pompermayer K, Amaral FA, Fagundes CT, Vieira AT, Cunha F de Q, Teixeira MM, Souza DG. Effects of the treatment with glibenclamide, an ATP-sensitive potassium channel blocker, on intestinal ischemia and reperfusion injury [Internet]. European Journal of Pharmacology. 2007 ; 556( 1-3): 215-222.[citado 2024 out. 15 ] Available from: https://doi.org/10.1016/j.ejphar.2006.10.065Vancouver
Pompermayer K, Amaral FA, Fagundes CT, Vieira AT, Cunha F de Q, Teixeira MM, Souza DG. Effects of the treatment with glibenclamide, an ATP-sensitive potassium channel blocker, on intestinal ischemia and reperfusion injury [Internet]. European Journal of Pharmacology. 2007 ; 556( 1-3): 215-222.[citado 2024 out. 15 ] Available from: https://doi.org/10.1016/j.ejphar.2006.10.065
